News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
01
2025
-
12
Linuo Pharmaceutical Holds a Rally to Kick Off the Fourth-Quarter Target Sprint and a Strategic Implementation Conference.
Classification：
行业新闻
Corporate News
10 Moon 7 day -8 On that day, the special marketing workshop for Linuo Pharmaceutical, the fourth-quarter target sprint mobilization meeting, and the strategic implementation and follow-up conference were held one after another in Jinan. The meetings comprehensively summarized... 1-9 The meeting reviewed various monthly tasks and focused on deploying the target tasks for the fourth quarter, emphasizing accountability and giving full throttle to the final sprint. Chairman Li Hongfu, President Huang Fangsheng, heads of all departments, and all marketing personnel attended the meeting.
The meeting kicked off with the rousing "Song of Linuo." The meeting began with a briefing on the company's strategic blueprint, clearly outlining the direction and key tasks for the fourth quarter. Heads of various departments delivered statements, committing to the work plans and goals for the fourth quarter and unanimously pledged to spare no effort in achieving all targets. The meeting placed particular emphasis on deploying the market strategies and policies for the fourth quarter, calling on each department to develop specific action plans to ensure that all tasks are effectively implemented.
To ensure the achievement of our goals, the meeting has laid out an organizational performance optimization plan centered on positive incentives, providing full support for marketing efforts. At the same time, a series of measures will be implemented in areas such as brand building, market promotion, and corporate culture development, offering systematic support for the realization of our business objectives.
The convening of this oath-taking rally has set the direction for Linuo Pharmaceutical’s fourth-quarter work and fostered a shared sense of purpose. All members of Linuo Pharmaceutical will, with even greater enthusiasm and a more pragmatic approach, make every effort to achieve the targets set for the fourth quarter, laying a solid foundation for meeting the annual targets and steadily propelling the company forward on the path of high-quality development.
Related news
2026-05-18
On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.
2026-05-13
On May 13, the 92nd National Pharmaceutical Fair and the 94th China International API, Intermediate, Packaging & Equipment Exhibition (API China) opened in grand style at the Shanghai National Exhibition and Convention Center. As an innovative, publicly listed company in China’s chemical pharmaceutical sector, Shandong Keyuan Pharmaceutical Co., Ltd. (301281.SZ), together with its wholly owned subsidiary Shandong Linuo Pharmaceutical Co., Ltd., made a high‑profile appearance, showcasing a coordinated approach to APIs and finished dosage forms, a comprehensive end-to-end product portfolio, and strong brand synergy. The company highlighted its robust capabilities in innovative R&D, digital and intelligent manufacturing, green production, global supply chains, and clinical translation, while engaging domestic and international partners to explore emerging industry trends, expand new avenues of collaboration, and co‑create a thriving new ecosystem for the pharmaceutical and healthcare sectors.
2026-05-07
On May 6, Lino Pharmaceutical, a subsidiary of Keyuan Pharmaceutical (stock code: 301281.SZ), held a company-wide meeting in Jinan. Centered on the core principle of “unified strategy across the entire workforce and coordinated action across all business units,” the meeting comprehensively communicated the company’s development strategy and outlined the implementation roadmap, aligning the thinking and building consensus among all employees. With a spirit of concerted effort and synchronized momentum, the meeting charted a new blueprint for the company’s high-quality development.
2026-05-07
Recently, the Jinan Municipal Federation of Trade Unions officially announced the list of winners for the 2025 “Making Contributions in the Spring City” Innovation and Excellence Labor Competition. Shandong Linuo Pharmaceutical Co., Ltd.’s Solid Dosage Form Workshop stood out among numerous outstanding work teams across the city thanks to its remarkable performance, rigorous work style, and exceptional innovative capabilities, earning the prestigious First Prize for Work Teams.
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China